UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 16

of 'Cellular and molecular biology of chronic myeloid leukemia'

16
TI
Cancer stem cell-directed therapies: recent data from the laboratory and clinic.
AU
Park CY, Tseng D, Weissman IL
SO
Mol Ther. 2009;17(2):219. Epub 2008 Dec 9.
 
Cancer stem cells (CSCs) are defined by their ability to (i) fully recapitulate the tumor of origin when transplanted into immunodeficient mouse hosts, and (ii) self-renew, demonstrated by their ability to be serially transplanted. These properties suggest that CSCs are required for tumor maintenance and metastasis; thus, it has been predicted that CSC elimination is required for cure. This prediction has profoundly altered paradigms for cancer research, compelling investigators to prospectively isolate CSCs to characterize the molecular pathways regulating their behavior. Many potential strategies for CSC-directed therapy have been proposed, but few studies have rigorously demonstrated their efficacy using in vivo models. Herein, we highlight recent studies that demonstrate the utility of CSC-directed therapies and discuss the implications of the CSC hypothesis to experimental design and therapeutic strategies.
AD
Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Palo Alto, California, USA. cypark@stanford.edu
PMID